{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:23:50Z","timestamp":1790900630143,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Goldfarb Advanced Fellowship in Breast Oncology at Dana-Farber Cancer Institute"},{"DOI":"10.13039\/100002597","name":"American Physicians Fellowship for Medicine in Israel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002597","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pinchas Borenstein Talpiot Medical Leadership Program, Chaim Sheba Medical Center, Tel-Hashomer, Israel"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s10549-022-06621-4","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T20:09:11Z","timestamp":1655496551000},"page":"597-606","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Outcomes after treatment of breast cancer during pregnancy including taxanes and\/or granulocyte colony-stimulating factor use: findings from a multi-institutional retrospective analysis"],"prefix":"10.1007","volume":"194","author":[{"given":"Tal","family":"Sella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Exman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor S.","family":"Freret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Economy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy U.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Moy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine M.","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann H.","family":"Partridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabihah","family":"Tayob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5430-8957","authenticated-orcid":false,"given":"Erica L.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,17]]},"reference":[{"issue":"1 Suppl","key":"6621_CR1","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/cncr.2820741341","volume":"74","author":"JA Petrek","year":"1994","unstructured":"Petrek JA (1994) Breast cancer during pregnancy. Cancer 74(1 Suppl):518\u2013527. https:\/\/doi.org\/10.1002\/cncr.2820741341","journal-title":"Cancer"},{"issue":"12","key":"6621_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27397","volume":"65","author":"RH Johnson","year":"2018","unstructured":"Johnson RH, Anders CK, Litton JK, Ruddy KJ, Bleyer A (2018) Breast cancer in adolescents and young adults. Pediatr Blood Cancer 65(12):e27397. https:\/\/doi.org\/10.1002\/pbc.27397","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"6621_CR3","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/AOG.0b013e3181b19154","volume":"114","author":"TM Andersson","year":"2009","unstructured":"Andersson TM, Johansson ALV, Hsieh CC, Cnattingius S, Lambe M (2009) Increasing incidence of pregnancy-associated breast cancer in Sweden. Obstet Gynecol 114(3):568\u2013572. https:\/\/doi.org\/10.1097\/AOG.0b013e3181b19154","journal-title":"Obstet Gynecol"},{"issue":"6","key":"6621_CR4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S1470-2045(21)00183-2","volume":"22","author":"F Amant","year":"2021","unstructured":"Amant F, Lefrere H, Borges VF, Cardonick E, Lambertini M, Loibl S, Peccatori F, Partridge A, Schedin P (2021) The definition of pregnancy-associated breast cancer is outdated and should no longer be used. Lancet Oncol 22(6):753\u2013754. https:\/\/doi.org\/10.1016\/S1470-2045(21)00183-2","journal-title":"Lancet Oncol"},{"issue":"3","key":"6621_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10549-017-4224-6","volume":"163","author":"GE Lee","year":"2017","unstructured":"Lee GE, Mayer EL, Partridge A (2017) Prognosis of pregnancy-associated breast cancer. Breast Cancer Res Treat 163(3):417\u2013421. https:\/\/doi.org\/10.1007\/s10549-017-4224-6","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"6621_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1200\/JCO.2008.17.4110","volume":"27","author":"H Stensheim","year":"2009","unstructured":"Stensheim H, Moller B, van Dijk T, Fossa SD (2009) Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 27(1):45\u201351. https:\/\/doi.org\/10.1200\/JCO.2008.17.4110","journal-title":"J Clin Oncol"},{"issue":"20","key":"6621_CR7","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1200\/jco.2012.45.6335","volume":"31","author":"F Amant","year":"2013","unstructured":"Amant F, von Minckwitz G, Han SN, Bontenbal M, Ring AE, Giermek J, Wildiers H, Fehm T, Linn SC, Schlehe B, Neven P, Westenend PJ, Muller V, Van Calsteren K, Rack B, Nekljudova V, Harbeck N, Untch M, Witteveen PO, Schwedler K, Thomssen C, Van Calster B, Loibl S (2013) Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol 31(20):2532\u20132539. https:\/\/doi.org\/10.1200\/jco.2012.45.6335","journal-title":"J Clin Oncol"},{"issue":"19","key":"6621_CR8","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa1508913","volume":"373","author":"F Amant","year":"2015","unstructured":"Amant F, Vandenbroucke T, Verheecke M, Fumagalli M, Halaska MJ, Boere I, Han S, Gziri MM, Peccatori F, Rob L, Lok C, Witteveen P, Voigt JU, Naulaers G, Vallaeys L, Van den Heuvel F, Lagae L, Mertens L, Claes L, Van Calsteren K, International Network on Cancer and Infertility Pregnancy (2015) Pediatric outcome after maternal cancer diagnosed during pregnancy. N Engl J Med 373(19):1824\u20131834. https:\/\/doi.org\/10.1056\/NEJMoa1508913","journal-title":"N Engl J Med"},{"key":"6621_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123616","author":"F Poggio","year":"2020","unstructured":"Poggio F, Tagliamento M, Pirrone C, Soldato D, Conte B, Molinelli C, Cosso M, Fregatti P, Del Mastro L, Lambertini M (2020) Update on the management of breast cancer during pregnancy. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12123616","journal-title":"Cancers (Basel)"},{"issue":"9","key":"6621_CR10","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S1470-2045(12)70261-9","volume":"13","author":"S Loibl","year":"2012","unstructured":"Loibl S, Han SN, von Minckwitz G, Bontenbal M, Ring A, Giermek J, Fehm T, Van Calsteren K, Linn SC, Schlehe B, Gziri MM, Westenend PJ, Muller V, Heyns L, Rack B, Van Calster B, Harbeck N, Lenhard M, Halaska MJ, Kaufmann M, Nekljudova V, Amant F (2012) Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol 13(9):887\u2013896. https:\/\/doi.org\/10.1016\/S1470-2045(12)70261-9","journal-title":"Lancet Oncol"},{"issue":"8","key":"6621_CR11","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1001\/jamaoncol.2015.2413","volume":"1","author":"S Loibl","year":"2015","unstructured":"Loibl S, Schmidt A, Gentilini O, Kaufman B, Kuhl C, Denkert C, von Minckwitz G, Parokonnaya A, Stensheim H, Thomssen C, van Calsteren K, Poortmans P, Berveiller P, Markert UR, Amant F (2015) Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients. JAMA Oncol 1(8):1145\u20131153. https:\/\/doi.org\/10.1001\/jamaoncol.2015.2413","journal-title":"JAMA Oncol"},{"issue":"1","key":"6621_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/2193-1801-2-297","volume":"2","author":"JL Meisel","year":"2013","unstructured":"Meisel JL, Economy KE, Calvillo KZ, Schapira L, Tung NM, Gelber S, Kereakoglow S, Partridge AH, Mayer EL (2013) Contemporary multidisciplinary treatment of pregnancy-associated breast cancer. Springerplus 2(1):297. https:\/\/doi.org\/10.1186\/2193-1801-2-297","journal-title":"Springerplus"},{"key":"6621_CR13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1717075","author":"TS Freret","year":"2020","unstructured":"Freret TS, Exman P, Mayer EL, Little SE, Economy KE (2020) Birthweight and chemotherapy exposure in women diagnosed with breast cancer during pregnancy. Am J Perinatol. https:\/\/doi.org\/10.1055\/s-0040-1717075","journal-title":"Am J Perinatol"},{"issue":"1","key":"6621_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70(1):41\u201355. https:\/\/doi.org\/10.1093\/biomet\/70.1.41","journal-title":"Biometrika"},{"issue":"2","key":"6621_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1515\/ijb-2012-0030","volume":"9","author":"L Li","year":"2013","unstructured":"Li L, Greene T (2013) A weighting analogue to pair matching in propensity score analysis. Int J Biostat 9(2):215\u2013234. https:\/\/doi.org\/10.1515\/ijb-2012-0030","journal-title":"Int J Biostat"},{"issue":"1","key":"6621_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pedneo.2014.03.010","volume":"56","author":"A Egbe","year":"2015","unstructured":"Egbe A, Uppu S, Lee S, Stroustrup A, Ho D, Srivastava S (2015) Congenital malformations in the newborn population: a population study and analysis of the effect of sex and prematurity. Pediatr Neonatol 56(1):25\u201330. https:\/\/doi.org\/10.1016\/j.pedneo.2014.03.010","journal-title":"Pediatr Neonatol"},{"issue":"3","key":"6621_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1470-2045(18)30059-7","volume":"19","author":"J de Haan","year":"2018","unstructured":"de Haan J, Verheecke M, Van Calsteren K, Van Calster B, Shmakov RG, Mhallem Gziri M, Halaska MJ, Fruscio R, Lok CAR, Boere IA, Zola P, Ottevanger PB, de Groot CJM, Peccatori FA, Dahl Steffensen K, Cardonick EH, Polushkina E, Rob L, Ceppi L, Sukhikh GT, Han SN, Amant F, International Network on Cancer and Infertility Pregnancy (2018) Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol 19(3):337\u2013346. https:\/\/doi.org\/10.1016\/S1470-2045(18)30059-7","journal-title":"Lancet Oncol"},{"issue":"1","key":"6621_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.clbc.2012.09.014","volume":"13","author":"F Zagouri","year":"2013","unstructured":"Zagouri F, Sergentanis TN, Chrysikos D, Dimitrakakis C, Tsigginou A, Zografos CG, Dimopoulos MA, Papadimitriou CA (2013) Taxanes for breast cancer during pregnancy: a systematic review. Clin Breast Cancer 13(1):16\u201323. https:\/\/doi.org\/10.1016\/j.clbc.2012.09.014","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"6621_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/cncr.21610","volume":"106","author":"S Loibl","year":"2006","unstructured":"Loibl S, von Minckwitz G, Gwyn K, Ellis P, Blohmer JU, Schlegelberger B, Keller M, Harder S, Theriault RL, Crivellari D, Klingebiel T, Louwen F, Kaufmann M (2006) Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer 106(2):237\u2013246. https:\/\/doi.org\/10.1002\/cncr.21610","journal-title":"Cancer"},{"key":"6621_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/01.AOG.0000558888.89911.f0","volume":"133","author":"ASS O\u2019Laughlin","year":"2019","unstructured":"O\u2019Laughlin ASS, Fleischer L, Akoto S, Cardonick E (2019) Safety of Taxane Chemotherapy in Breast Cancer During Pregnancy [28O]. Obstet Gynecol 133:169\u2013170. https:\/\/doi.org\/10.1097\/01.AOG.0000558888.89911.f0","journal-title":"Obstet Gynecol"},{"issue":"12","key":"6621_CR21","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1093\/annonc\/mds170","volume":"23","author":"E Cardonick","year":"2012","unstructured":"Cardonick E, Bhat A, Gilmandyar D, Somer R (2012) Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature. Ann Oncol 23(12):3016\u20133023. https:\/\/doi.org\/10.1093\/annonc\/mds170","journal-title":"Ann Oncol"},{"issue":"2","key":"6621_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/annonc\/mdp517","volume":"21","author":"O Mir","year":"2010","unstructured":"Mir O, Berveiller P, Goffinet F, Treluyer JM, Serreau R, Goldwasser F, Rouzier R (2010) Taxanes for breast cancer during pregnancy: a systematic review. Ann Oncol 21(2):425\u2013426. https:\/\/doi.org\/10.1093\/annonc\/mdp517","journal-title":"Ann Oncol"},{"issue":"1","key":"6621_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/AOG.0000000000000602","volume":"125","author":"LA Boxer","year":"2015","unstructured":"Boxer LA, Bolyard AA, Kelley ML, Marrero TM, Phan L, Bond JM, Newburger PE, Dale DC (2015) Use of granulocyte colony-stimulating factor during pregnancy in women with chronic neutropenia. Obstet Gynecol 125(1):197\u2013203. https:\/\/doi.org\/10.1097\/AOG.0000000000000602","journal-title":"Obstet Gynecol"},{"issue":"8","key":"6621_CR24","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3324\/haematol.2013.099101","volume":"99","author":"C Zeidler","year":"2014","unstructured":"Zeidler C, Grote UA, Nickel A, Brand B, Carlsson G, Cortesao E, Dufour C, Duhem C, Notheis G, Papadaki HA, Tamary H, Tjonnfjord GE, Tucci F, Van Droogenbroeck J, Vermylen C, Voglova J, Xicoy B, Welte K (2014) Outcome and management of pregnancies in severe chronic neutropenia patients by the European branch of the severe chronic neutropenia international registry. Haematologica 99(8):1395\u20131402. https:\/\/doi.org\/10.3324\/haematol.2013.099101","journal-title":"Haematologica"},{"key":"6621_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061214","author":"C Berends","year":"2021","unstructured":"Berends C, Maggen C, Lok CAR, van Gerwen M, Boere IA, Wolters V, Van Calsteren K, Segers H, van den Heuvel-Eibrink MM, Painter RC, Gziri MM, Amant F (2021) Maternal and neonatal outcome after the use of G-CSF for cancer treatment during pregnancy. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13061214","journal-title":"Cancers (Basel)"},{"issue":"6","key":"6621_CR26","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1097\/AOG.0b013e31826c32d9","volume":"120","author":"E Cardonick","year":"2012","unstructured":"Cardonick E, Gilmandyar D, Somer RA (2012) Maternal and neonatal outcomes of dose-dense chemotherapy for breast cancer in pregnancy. Obstet Gynecol 120(6):1267\u20131272. https:\/\/doi.org\/10.1097\/AOG.0b013e31826c32d9","journal-title":"Obstet Gynecol"},{"issue":"2","key":"6621_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4236\/jct.2012.32021","volume":"3","author":"EIF Cardonick","year":"2012","unstructured":"Cardonick EIF, Torres N (2012) The use of neupogen (Filgrastim) or Neulasta (Pegfilgrastim) during pregnancy when chemotherapy is indicated for maternal cancer treatment. J Cancer Ther 3(2):157\u2013161. https:\/\/doi.org\/10.4236\/jct.2012.32021","journal-title":"J Cancer Ther"},{"key":"6621_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2019.08.001","volume":"79","author":"F Zagouri","year":"2019","unstructured":"Zagouri F, Korakiti AM, Zakopoulou R, Kyriazoglou A, Zografos E, Haidopoulos D, Apostolidou K, Papatheodoridi MA, Dimopoulos MA (2019) Taxanes during pregnancy in cervical cancer: a systematic review and pooled analysis. Cancer Treat Rev 79:101885. https:\/\/doi.org\/10.1016\/j.ctrv.2019.08.001","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"6621_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100262","volume":"6","author":"A Andrikopoulou","year":"2021","unstructured":"Andrikopoulou A, Korakiti AM, Apostolidou K, Dimopoulos MA, Zagouri F (2021) Immune checkpoint inhibitor administration during pregnancy: a case series. ESMO Open 6(5):100262. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100262","journal-title":"ESMO Open"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06621-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-022-06621-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06621-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T04:24:48Z","timestamp":1657859088000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-022-06621-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["6621"],"URL":"https:\/\/doi.org\/10.1007\/s10549-022-06621-4","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,17]]},"assertion":[{"value":"27 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Heather A. Parsons has received funding to the institution from Puma. Nancy U. Lin has received grant\/contract funding to the institution from Genentech, Merck, Pfizer, Seattle Genetics, Zion Pharmaceuticals, Olema Pharmaceuticals, and AstraZeneca; consulting fees\/honorarium for consulting\/ad board participation from Puma, Seattle Genetics, AstraZeneca, Daiichi-Sankyo, Denali Therapeutics, Olema Pharma, Prelude Therapeutics, Aleta BioPharma, Voyager Therapeutics, Affinia Therapeutics, and Pfizer; royalties from UpToDate;\u00a0and stock and other ownership interests in Artera Inc. Nadine M. Tung has received research funding from AstraZeneca. Erica L. Mayer has received consulting\/advising fees from Novartis, Lilly, Gilead, and AstraZeneca. All remaining authors declared that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}